Lindsay Therrien is a proficient professional in molecular oncology and account management, currently serving as a Senior Molecular Oncology Specialist at Agendia since November 2023. Prior experience includes roles such as Key Account Manager at Epic Sciences, where a novel blood-based test for metastatic breast cancer was integrated into the laboratory menu, and Director of Clinical Partnerships-West at BostonGene. Lindsay also held multiple roles at Myriad Genetics, focusing on oncology sales, training management, and successful collaboration with NCCN institutions. Early career experiences include business development at Clinical Genomics, account management at Myriad Genetics, and a role as Graduate Admissions Coordinator at the University of Utah. Educational qualifications include a Master of Science in Child and Family Studies from the University of Tennessee and a Bachelor of Arts in Marketing from Pepperdine University.